BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$9.12
−4.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.31x
- Price / sales
- 3.21x
- Price / cash flow
- -51.34x
Enterprise value
- Enterprise value
- $112.9M
- EV / sales
- 2.98x
- EV / EBITDA
- -10.16x
- EV / EBIT
- -8.98x
- Market cap
- $121.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026